MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, insurance bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
IPO Year: 2020
Exchange: NYSE
Website: multiplan.us
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 6/26/2024 | $2.00 | Neutral | Piper Sandler |
| 12/13/2022 | $3.00 → $2.00 | Buy → Neutral | Citigroup |
| 7/12/2022 | $6.50 | Neutral | Goldman |
| 12/20/2021 | $9.00 → $7.00 | Buy | Citigroup |
| 11/11/2021 | $7.00 → $6.00 | Equal-Weight | Barclays |
| 10/4/2021 | $9.00 | Buy | Citigroup |
| 8/20/2021 | $9.00 | Buy | Tigress Financial |
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
3 - MultiPlan Corp (0001793229) (Issuer)
3 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
3 - MultiPlan Corp (0001793229) (Issuer)
4 - MultiPlan Corp (0001793229) (Issuer)
3 - MultiPlan Corp (0001793229) (Issuer)
– Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,
MultiPlan Corporation (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, is accepting applications for its Rural Health Grant now through December 15, 2024 from rural healthcare providers in the U.S. The grants provide financial resources to introduce or expand services, education, screenings and other programs aimed at improving the health of people in their communities. The MultiPlan Rural Health Grant is available to hospitals, rural health clinics and federally qualified health centers participating in any of MultiPlan's healthcare provider networks, includin
Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, announced today that it will release its third quarter 2024 financial results on Tuesday, November 5, 2024, and hold its conference call that morning at 8:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=95da760a&confId=71678. Upon registration, you will receive an email with the conference dial-in details and a unique access co
Curren Katz Named Senior Vice President, Chief Data Science Officer Tara O'Neil Promoted to General Counsel; Scott Mays Promoted to SVP, Legal and Deputy General Counsel MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced an addition to its leadership team and two internal promotions within its Legal team, showcasing the company's deep pool of talent. Curren Katz, PhD has been appointed Chief Data Science Officer. In this newly created role, Katz will lead and unify the company's efforts and ac
Uniting the combined strengths of two leading healthcare organizations to address financial barriers to patient care. MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, and the National Rural Health Association (NRHA), a non-profit membership organization that provides leadership on rural health issues, announced today a strategic alliance to improve access to high-quality healthcare services in rural communities by empowering rural healthcare providers with innovative technology and actionable insights. In to
MultiPlan Common Stock to Begin Trading on a Split-Adjusted Basis on September 23, 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, today announced that the previously announced 1-for-40 reverse stock split of its outstanding shares of Class A common stock (the "common stock") became effective as of September 20, 2024 at 5:00 p.m. Eastern Time (the "Split Effective Time"). The common stock will continue trading on the New York Stock Exchange ("NYSE") under the existing symbol (MPLN) and will begin trading on a split-adjusted bas
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer
MultiPlan Common Stock Expected to Begin Trading on a Split-adjusted Basis on September 23, 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, today announced that it expects a 1-for-40 reverse stock split of its outstanding shares of Class A common stock (the "common stock") will be effective as of September 20, 2024 at 5:00 p.m. Eastern Time. MultiPlan's common stock will continue trading on the New York Stock Exchange ("NYSE") under the existing symbol (MPLN) and will begin trading on a split-adjusted basis when the market open
Employees commended the company's inclusive, supportive, and diverse workplace culture MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, is proud to announce it has been Certified™ by Great Place to Work® for the third consecutive year. In surveying current employees this year about their experience working at MultiPlan, 87% said it's a great place to work – far above the 57% overall satisfaction of employees at a typical U.S.-based company. Great Place To Work® is the global authority on workplace culture, employee experience, and
Tiffani Misencik Named Chief Growth Officer in New Executive Leadership Role MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today announced a new addition to its executive leadership team to support the next phase of the Company's strategic growth. Tiffani Misencik has been appointed Chief Growth Officer. In this newly created role, Misencik will oversee MultiPlan's sales and revenue growth strategy across all market segments. She will lead the company's efforts in client acquisition, client management, an
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. health care industry, is honored to announce it has been named in the 2024 Fortune Best Workplaces in Health Care™ List. based on its 2023-2024 Great Place to Work® Certification™ results. This is the second time MultiPlan has been named in the Best Workplaces in Health Care list. Earning a spot means that MultiPlan is one of the best companies to work for in the country. The Best Workplaces in Health Care list is based on analysis of survey responses from over 185,000 employees from Great Place To Work Cer
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today its CFO transition plan and named Doug Garis as EVP and CFO, effective August 5, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240731993142/en/Doug Garis named EVP and CFO of MultiPlan (Photo: Business Wire) Jim Head, who has served as EVP and CFO of MultiPlan since November 2021, will transition to a Strategic Advisor role to the Company through the end of the
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions, to the U.S. healthcare industry, today announced that Great Place To Work® and Fortune magazine have recognized the Company as one of the Best Workplaces in New York™ for 2024. This marks the second consecutive year MultiPlan has been named to this prestigious list. "Our inclusion on this list makes clear the unwavering investment we make in our employees' long-term success," said Carol Nutter, SVP and Chief People Officer at MultiPlan. "MultiPlan prides itself on maintainin
Hogge's Growth-Driven Expertise Bolsters MultiPlan's Next Phase of Growth and Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced that Jerry Hogge will join the Company as Executive Vice President, Chief Operating Officer (COO). Hogge is a highly accomplished operational and commercial leader who has excelled within the healthcare and telecommunications industries for over 30 years. He has a wide range of experience driving operational efficiency and growth in compl
Transition Aligned with Company's Growth Strategy and Next Phase of Product Innovation MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, announced that Travis Dalton will join the Company as President and CEO on March 1, 2024. He will succeed Dale White, who will remain active as Executive Chair of the Company, succeeding current Chair Mark Tabak. With over 20 years in healthcare technology leadership positions at Cerner Corporation and Oracle Health, Mr. Dalton is a proven leader with deep experience in leveraging technology, data
Appointment of new SVP of Marketing and Communications and SVP of Products support the next phase of the Company's Growth Plan MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, today announced the appointment of Melissa Humphrey to Senior Vice President of Marketing and Communications and the promotion of Andrea Rowe to Senior Vice President of Products. As MultiPlan's new SVP of Marketing and Communications, Humphrey will oversee the company's brand reputation, product marketing, client co
Adds significant payor industry expertise and bolsters next phase of company's growth plan MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading provider of technology and data-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, today announced the appointment of John Prince to its Board of Directors, effective June 26, 2023. Prince has more than 25 years of executive leadership experience running businesses in healthcare services and technology and managing enterprise functions spanning strategy, corporate development, operations, and technology for healthcare payors and providers, bringing a valuable depth of expertise
MultiPlan Corporation (NYSE:MPLN) ("MultiPlan" or the "Company"), a leading value-added provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, today announced that Dale White will assume the title of Chief Executive Officer on February 1, 2022 in accordance with the Company's previously announced executive transition plan. Mr. White succeeds Mark Tabak. Since joining MultiPlan in 2004, Mr. White has held a variety of key leadership positions, most recently President and Chief Operating Officer. Along with his elevation to CEO, Mr. White has been appointed as a member of the Board of Directors and will serve as a Class III Dir
Dr. Perryman to prioritize and operationalize data science opportunities across cost-management, payment, and revenue integrity solutions MultiPlan Corporation (NYSE:MPLN) a leading provider of data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the U.S. healthcare industry, announces the appointment of Benjamin Perryman, PhD, to Vice President, Data Science Operations. In the new position, Dr. Perryman will implement an agile methodology focused on continuous delivery of client-centric analytical insights. Dr. Perryman's appointment is a part of MultiPlan's continued investment in systems and service infrastructure to support the delivery o
– Q3 2024 Revenues of $230.5 million, Net Loss of $391.5 million (including a $361.6 million impairment of goodwill and indefinite-lived intangibles), and Adjusted EBITDA of $141.6 million – Identified potential medical cost savings of approximately $6.4 billion in Q3 2024, up 10% from Q3 2023 and up 3% from Q2 2024 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton said,
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading provider of data-driven cost management solutions that deliver transparency and promote fairness, quality and affordability to the U.S. healthcare industry, announced today that it will release its third quarter 2024 financial results on Tuesday, November 5, 2024, and hold its conference call that morning at 8:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=95da760a&confId=71678. Upon registration, you will receive an email with the conference dial-in details and a unique access co
– Q2 2024 Revenues of $233.5 million, Net Loss of $576.7 million (including a $553.7 million impairment of goodwill), and Adjusted EBITDA of $146.7 million – Identified potential medical cost savings of approximately $6.2 billion in Q2 2024, up 9% from Q2 2023 and up 8% from Q1 2024 – CFO transition plan announced MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the second quarter ended June 30, 2024 and updated its full-year 2024 guidance. CEO Travis Dalton s
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, as well as payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its second quarter 2024 financial results on Thursday, August 1, 2024, and hold its conference call that morning at 9:30 am Eastern Time. To join the conference call, please pre-register using the following link at least 10 minutes before the call begins: https://www.netroadshow.com/events/login?show=f096f8c3&confId=66913. Upon registration, you will receive an email with the conference dial-in details and
– Q1 2024 Revenues of $234.5 million, Net Loss of $539.7 million (including a $519.1 million impairment of goodwill and indefinite-lived intangible assets), and Adjusted EBITDA of $146.8 million – Identified potential medical cost savings of approximately $5.7 billion in Q1 2024, up 3% from Q1 2023 and down 3% from Q4 2023 – Repurchased or repaid $24.4 million of face value of debt, including $21.1 million of 6.0% Senior Convertible PIK Notes MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today r
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its first quarter 2024 financial results on Wednesday, May 8, 2024, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, go to:
– Q4 2023 Revenues of $244.1 million, Net Loss of $31.4 million and Adjusted EBITDA of $156.8 million – Full Year 2023 Revenues of $961.5 million, Net Loss of $91.7 million and Adjusted EBITDA of $618.0 million – Identified potential medical cost savings of approximately $5.9 billion in Q4 2023, up 2.3% from Q3 2023 and up 9.4% from Q4 2022 – In Full Year 2023, the Company deployed cash of $140.9 million for the acquisition of Benefits Science LLC ("BST"), $165.8 million toward open-market debt repurchases and repayment, and $15.2 million toward share repurchases – Full Year 2024 Revenues guidance of $1,000 million to $1,030 million and FY 2024 Adjusted EBITDA guidance of $630 milli
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, announced today that it will release its fourth quarter and full year 2023 financial results on Thursday, February 29, 2024, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To
– Q3 2023 Revenues of $242.8 million, Net Loss of $24.1 million, and Adjusted EBITDA of $152.3 million – Identified potential medical cost savings of approximately $5.8 billion in Q3 2023, up 2% from Q2 2023 and up 7% from Q3 2022 – Repurchased an additional $46.1 million in face value of our 5.75% Senior Unsecured Notes in the open market in Q3 2023 MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today reported financial results for the third quarter ended September 30, 2023. "The third quarter
MultiPlan Corporation ("MultiPlan" or the "Company") (NYSE:MPLN), a leading value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry, today announced that it will release its third quarter 2023 financial results on Tuesday, November 7, 2023, and hold its conference call that morning at 8:00 am Eastern Time. Investors and analysts are encouraged to pre-register for the conference call by using the link below. Participants who pre-register will receive access details via email. Pre-registration may be completed at any time up to and following the start of the call. To pre-register, go
10-Q - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
S-8 - MultiPlan Corp (0001793229) (Filer)
S-8 POS - MultiPlan Corp (0001793229) (Filer)
10-Q - MultiPlan Corp (0001793229) (Filer)
8-K - MultiPlan Corp (0001793229) (Filer)
Piper Sandler initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $2.00
Citigroup downgraded MultiPlan from Buy to Neutral and set a new price target of $2.00 from $3.00 previously
Goldman initiated coverage of MultiPlan with a rating of Neutral and set a new price target of $6.50
Citigroup reiterated coverage of MultiPlan with a rating of Buy and set a new price target of $7.00 from $9.00 previously
Barclays reiterated coverage of MultiPlan with a rating of Equal-Weight and set a new price target of $6.00 from $7.00 previously
Citigroup resumed coverage of MultiPlan with a rating of Buy and set a new price target of $9.00
Tigress Financial initiated coverage of MultiPlan with a rating of Buy and set a new price target of $9.00
B. Riley FBR initiated coverage of MultiPlan with a rating of Buy and set a new price target of $10.00
Barclays initiated coverage of MultiPlan with a rating of Equal Weight and set a new price target of $7.00
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13G/A - MultiPlan Corp (0001793229) (Subject)
SC 13D/A - MultiPlan Corp (0001793229) (Subject)
Piper Sandler analyst Jessica Tassan initiates coverage on MultiPlan (NYSE:MPLN) with a Neutral rating and announces Price Target of $2.
Gainers Anitra (AMEX:AZTR) shares increased by 6.5% to $0.18 during Wednesday's after-market session. The market value of their outstanding shares is at $5.1 million. Oragenics (AMEX:OGEN) shares increased by 4.24% to $2.04. The market value of their outstanding shares is at $9.1 million. PACS Group (NYSE:PACS) shares rose 3.95% to $31.52. The market value of their outstanding shares is at $4.8 billion. MultiPlan (NYSE:MPLN) shares moved upwards by 3.49% to $0.45. The market value of their outstanding shares is at $290.3 million. Nanoviricides (AMEX:NNVC) stock moved upwards by 2.01% to $2.48. The market value of their outstanding shares is at $29.2 million. Calidi Biotherapeutics (AME
Shares of Lands’ End, Inc. (NASDAQ:LE) fell sharply during Wednesday's session following first-quarter results. Lands’ End reported quarterly adjusted loss of 20 cents per share which beat the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $285.47 million which beat the analyst consensus estimate of $269.82 million, according to data from Benzinga Pro. Lands’ End shares dipped 9.3% to $12.60 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers Actelis Networks, Inc. (NASDAQ:ASNS) shares jumped 512% to $2.88 after the company announced orders for cyber-hardened networking technology to be deployed at thr
Gainers Concord Medical Services (NYSE:CCM) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. Calidi Biotherapeutics (AMEX:CLDI) stock increased by 4.26% to $0.21. The market value of their outstanding shares is at $10.8 million. Anitra (AMEX:AZTR) shares moved upwards by 2.69% to $0.18. The market value of their outstanding shares is at $5.0 million. MAIA Biotechnology (AMEX:MAIA) stock rose 0.79% to $3.79. The company's market cap stands at $82.7 million. Emergent BioSolutions (NYSE:EBS) shares moved upwards by 0.53% to $5.59. The market value of their outstanding shares is at $292.9 million. Asensus Surg
Shares of GameStop Corp. (NYSE:GME) rose sharply in today's pre-market trading after the company announced it has completed its at-the-market equity offering program, which was previously announced. The company sold 45 million shares under the plan with aggregate gross proceeds of $933.4 million. GameStop shares jumped 17.6% to $22.35 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers Sharps Technology, Inc. (NASDAQ:STSS) rose 131.2% to $0.4954 in today's pre-market trading after jumping around 13% on Friday. Calliditas Therapeutics AB (NASDAQ:CALT) shares gained 74.6% to $38.10 in pre-market trading after the company's boar
U.S. stock futures were mostly higher this morning, with the Nasdaq futures gaining around 0.5% on Tuesday. Shares of Hello Group Inc. (NASDAQ:MOMO) fell sharply in today's pre-market trading following first-quarter results. Hello Group posted adjusted EPADS of 4 cents, compared to market expectations of 29 cents. The company's sales came in at $354.61 million versus estimates of $347.95 million, according to data from Benzinga Pro. Hello Group shares fell 4.9% to $5.25 in pre-market trading. Here are some big stocks recording losses in today's pre-market trading session. MultiPlan Corporation (NYSE:MPLN) shares dipped 9.8% to $0.6198 in pre-market trading after jumping 22% o
Gainers Innovative Eyewear (NASDAQ:LUCY) shares moved upwards by 421.5% to $0.97 during Monday's regular session. The company's market cap stands at $16.9 million. OneMedNet (NASDAQ:ONMD) shares moved upwards by 55.78% to $2.29. The company's market cap stands at $54.6 million. Qilian Intl Hldg Gr (NASDAQ:QLI) shares moved upwards by 37.59% to $0.91. The company's market cap stands at $32.4 million. Onconetix (NASDAQ:ONCO) shares moved upwards by 29.7% to $0.18. The market value of their outstanding shares is at $4.0 million. TransCode Therapeutics (NASDAQ:RNAZ) shares moved upwards by 28.77% to $1.79. The company's market cap stands at $11.8 million. MultiPlan (NYSE:MPLN) stock rose 2
Gainers IGM Biosciences (NASDAQ:IGMS) shares increased by 36.6% to $11.49 during Wednesday's regular session. The market value of their outstanding shares is at $678.1 million. Akso Health Group (NASDAQ:AHG) stock moved upwards by 21.96% to $1.05. The company's market cap stands at $153.8 million. MultiPlan (NYSE:MPLN) shares rose 18.57% to $0.64. The company's market cap stands at $415.4 million. Cyclerion Therapeutics (NASDAQ:CYCN) shares rose 14.61% to $2.98. The company's market cap stands at $7.4 million. TransCode Therapeutics (NASDAQ:RNAZ) shares increased by 12.79% to $1.41. The company's market cap stands at $9.3 million. Indaptus Therapeutics (NASDAQ:INDP) shares moved upward
The Dow Jones index closed lower by 0.5% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform. MultiPlan The Trade: MultiPlan Corporation (NYSE:MPLN) Director Anthony Colaluca Jr bought a total of 160,000 shares at an average price of $0.60. To acquire these shares, it cost around $96,000. What's Happening: On May 8, MultiPlan posted a GAAP loss of